Job title
Translational Scientist - Prof Owen Sansom
Job reference
REQ00337
Date posted
09/05/2024
Application closing date
09/06/2024
Location
Glasgow
Salary
£35,000 to £50,000 (Depending on experience)
Package
Relocation allowance where relevant and visa costs reimbursed if required.
Contractual hours
35
Basis
Full time
Job category/type
Scientific Officers
Attachments
Blank
Job description
Scotland Institute lab:Colorectal Cancer and Wnt Signalling
Salary: £35,000 to £50,000 (Depending on experience) plus relocation allowance and Visa costs if required.
Contract Term : Fixed up to 1 year.
About us
The CRUK Scotland Institute (formerly Beatson Institute) is a cancer research institute, situated in Glasgow with approximately 250 researchers split across 30 research groups consisting of PIs, postdoctoral scientists, PhD students and scientific officers. It is one of Europe's leading cancer research centres, supporting cutting-edge work into the molecular mechanisms of cancer development. As well as core support from Cancer Research UK, the Institute also receives an additional third of its total income from external grants and industry collaborations. It has an excellent reputation for fundamental cancer research, including world-class metabolism studies and renowned in vivo modelling of tumour growth and metastasis. Its research ethos is about excellence, honesty, openness, accountability and integrity.
Position outline
A Senior/Principal scientific officer position is available for a translationally minded scientist to join the Colorectal Cancer and Wnt Signalling team to drive preclinical research. The project will require the delivery of biopharma-funded translational research and will focus upon development of novel therapeutic approaches relevant to colorectal cancer, related to the WNT and RAS signalling pathways. Both in vitro and in vivo will be undertaken in delivering this project, which will determine the therapeutic efficacy of WNT or RAS pathway targeting. Briefly, the project involves the transcriptional and functional characterisation of pharmacomimetic loss-of-function mutations in murine models of colorectal cancer.
As an ideal candidate, you will be an experienced researcher having completed at least one position after completion of a relevant PhD. You must have expertise in working with murine cancer models, and have a strong background in molecular biology and cellular signalling. The ability to work as part of a team and to effectively plan and prioritize workflows to facilitate project delivery will be an advantage.
For informal enquiries about the research, please email Dr. Andrew Campbell at [email protected]
Equality, Diversity and Inclusion
Our overarching research ethos at the Institute is about excellence, honesty, openness, accountability and integrity. The diversity of our staff and students is also what makes the Institute such a vibrant place to work and advance discoveries in cancer research. Family friendly policies, our collaborative ethos, a focus on good mental health and well-being and opportunities for all help to create an enjoyable and inclusive workplace where your voice matters.
Employee Benefits
Closing Date for applications: 09 June 2024